TPG Group Holdings (SBS) Advisors, Inc.
Institutional investor · Portfolio as of Q2 2015No 13F holdings reported for quarters after Q3 2021. Holdings now reported by TPG GP A.
Top Holdings44 positions
1793264 | 197M | $7.9B | 36.3% | — | — | 3 qtrssince 2014-Q4 | Increased 63 |
12571 | 123.3M | $3.8B | 17.4% | — | — | 3 qtrssince 2014-Q4 | Decreased 0 |
ZIMMER BIOMET HOLDINGS INC | 30.1M | $3.3B | 15.2% | $97.38 | 0.00% | 1 qtr | New 99 |
SABRE CORP | 112.2M | $2.7B | 12.3% | $17.75 | +16.73% | 3 qtrssince 2014-Q4 | Decreased 0 |
| 9M | $650.3M | 3.0% | — | — | 3 qtrssince 2014-Q4 | Decreased 0 | |
Surgical Care Affiliates, Inc. | 16.2M | $620.1M | 2.9% | — | — | 3 qtrssince 2014-Q4 | Decreased 0 |
LPL FINL HLDGS INC | 12.9M | $599.1M | 2.8% | $38.17 | +5.58% | 3 qtrssince 2014-Q4 | Unchanged 0 |
| 23.7M | $412.7M | 1.9% | — | — | 3 qtrssince 2014-Q4 | Unchanged 0 | |
NORWEGIAN CRUISE LINE HLDG L | 7.3M | $410.8M | 1.9% | $46.86 | +18.22% | 3 qtrssince 2014-Q4 | Decreased 0 |
| 8.7M | $171.7M | 0.8% | — | — | 3 qtrssince 2014-Q4 | Unchanged 0 | |
| 17.7M | $147.5M | 0.7% | — | — | 1 qtr | New 60 | |
AV Homes Inc. | 9.2M | $132.4M | 0.6% | — | — | 3 qtrssince 2014-Q4 | Unchanged 0 |
ALDER BIOPHARMACEUTICALS INC | 1.2M | $65.6M | 0.3% | — | — | 3 qtrssince 2014-Q4 | Decreased 0 |
ULTRAGENYX PHARMACEUTICAL INC COM | 596,420 | $61.1M | 0.3% | $44.04 | +123.52% | 3 qtrssince 2014-Q4 | Decreased 0 |
| 2M | $52.2M | 0.2% | — | — | 3 qtrssince 2014-Q4 | Increased 47 | |
Interactive Brokers Group Inc | 1.2M | $51.3M | 0.2% | $7.10 | +33.37% | 3 qtrssince 2014-Q4 | Increased 38 |
Otonomy, Inc. | 2.2M | $49.6M | 0.2% | — | — | 3 qtrssince 2014-Q4 | Unchanged 0 |
VERINT SYSTEMS INC | 788,255 | $47.9M | 0.2% | — | — | 3 qtrssince 2014-Q4 | Increased 43 |
Sixth Street Specialty Lending, | 2.8M | $47.1M | 0.2% | $5.45 | +7.34% | 3 qtrssince 2014-Q4 | Decreased 0 |
Evolent Health, Inc. | 2.4M | $46.5M | 0.2% | $18.85 | 0.00% | 1 qtr | New 49 |
TPG Group Holdings (SBS) Advisors, Inc. reported holdings worth $21.7B across 44 positions as of Q2 2015. Top holdings: FSL (36.3%), IMS (17.4%), ZBH (15.2%). Fund DNA: Balanced Allocator.
Top holdings by portfolio weight
Portfolio allocation by GICS sector
Behavioral investing profile
Position Outcomes
Best and worst performing positions by estimated return
Top Winners
Top Losers
Cost basis estimates based on full filing history using quarter-end prices. Actual transaction prices are not disclosed in 13F filings.
Similar Funds
Funds with similar investing DNA
Explore More
Accumulation Streaks
Positions with 2+ consecutive quarters of increases - persistent directional conviction.
No active accumulation streaks detected for this filer.
Streaks require 2+ consecutive quarters of increased positions in the most recent period.
Continue exploring
Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer
Verify source filings on SEC EDGAR